We raised our Series A after initially facing many rejections, but ultimately secured $3-4 million from various investors.

The hardest part of raising our Series A was overcoming the perception that we were just two academics without a viable business model.

Despite initial struggles, we showed some growth, prompting an investor to suggest we raise a Series A round, which I eagerly prepared for.

Despite progress, raising Series A was challenging due to increased competition in the food startup space, and we faced another setback in securing funding.

Despite facing a down round during our Series C funding, we continued to grow the business and raise additional capital, demonstrating resilience in a competitive market.

After launching our first product, we received positive feedback from investors, but I was unaware that we were about to face a long period of struggle.

We were confident about our startup, thinking we would get a lot of PR and funding, and we did receive significant media attention and raised $1.2 million in funding.

After raising our seed round, we went on to raise about $20 million more in venture capital, taking our device through prototype stages and clinical studies, ultimately achieving FDA clearance.

I didn't sell my story well to investors, which led to challenges in raising funds, but eventually, we built a strong case that made it hard for them to ignore us.